Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017472-25Phase 4Active
Phase 4, open-label, single-arm trial of 10XB101 and sodium chloride in Varicose Veins and venous stasis, sponsored by Universitätsklinikum Schleswig-Holstein. Primary endpoint: Complete occlusion of the great saphenous vein. Started Jan 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017472-25.